Bank of America Comments on St Jude Medical

Bank of America has published a research report on St Jude Medical STJ. In the report, Bank of America wrote, "With MDT's report yesterday all public CRM companies have now reported for Q2. CRM makes up 30% of MDT, 55% of STJ and 27.5% of BSX revenues." Bank of America rated St. Jude Medical a BUY with a price target of $59.00. St. Jude Medical closed Wednesday at $44.02.